Briumvi Injection, Solution, Concentrate
Product Images NDC 73150-150

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Briumvi (NDC 73150-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tg Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (6 mL Carton Label)

This is a drug information sheet for Briumvi (ublituximab-xiiy) injection, which is used for intravenous infusion after dilution. Each vial contains 150 mg of ublituximab-xiiy in 6 mL of solution. It must be diluted in 0.9% Sodium Chloride Injection, USP prior to use. The dosage should be followed as per prescribing information. The medication needs to be refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light, and should not be shaken or frozen. Contains one 6 mL single-dose vial. The manufacturer is TG Therapeutics, Inc., Morrisville, NC 27560.*

FDA Label Image

Principal Display Panel (6 mL Vial Label)

This is a medication with LOT number 012345, expiration date DDMMMYYYY, NDC code 73150-150-06, and dosage instructions which are provided in the prescribing information. It is a single-dose vial without preservatives and must be stored refrigerated at 2°C to 8°C (36-46°F) in its original carton to protect it from light. It contains ublituximab and is manufactured by TG Therapeutics, Inc. for intravenous infusion after dilution. The medication must not be frozen or shaken, and any unused portion must be discarded. The text also includes some illegible characters, so this may not be a complete description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.